GPRC5a is over expressed in pancreatic, breast, gastric and colon cancer, and it has been shown that overexpression of RAI3 predict poor prognosis in hepatocellular carcinoma [5–11]. This evidence concerns the gene GPRC5A and colonic neoplasm.